期刊文献+

罗格列酮与二甲双胍治疗初诊老年2型糖尿病疗效分析 被引量:3

暂未订购
导出
作者 党治虎
出处 《实用老年医学》 CAS 2006年第2期140-141,共2页 Practical Geriatrics
  • 相关文献

参考文献4

二级参考文献16

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2谢明智 刘海帆 等.实验性肥胖及糖尿病大鼠模型[J].药学学报,1985,20(11):801-801.
  • 3Napoli R, Hirshman MF, Horton ES. Mechanism and time couse of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats[J]. J Clin Invest, 1995,96:427.
  • 4Moil S,Kawano K,Hivashima T, et al. Relationships between diet contronl and the development of spontaneous type 2 diabetes and diabetic nephropathy in OLETF rats [ J ]. Diabetic Res Clin Prac, 1996, 33 : 145.
  • 5Garvey WT,Maianu L, Zhu JH, et al. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes : heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters[J]. Diabetes, 1993,42 : 1773.
  • 6Sahiel AR, Olefsky JM. Thiazolinediones in the treatment insulin resistant and type 2 diabetes[J]. Diabetes, 1996,45 : 1661.
  • 7钟学礼.临床糖尿病[M].上海:上海科学技术出版社,1989.145.
  • 8李益明,段文澜,朱禧星,左嘉客.二甲双胍对糖尿病大鼠骨骼肌GLUT4基因表达的影响[J].上海医科大学学报,1998,25(6):409-411. 被引量:5
  • 9李晨钟.胰岛素增敏剂研究新进展[J].国外医学(内分泌学分册),1999,19(1):29-32. 被引量:21
  • 10左孟华,钱东华,杜文波,郑辉.老年人下呼吸道感染致病菌的分布和耐药[J].中国老年学杂志,2001,21(4):275-276. 被引量:16

共引文献6

同被引文献14

  • 1Nauck MA, Heimesaat MM, Behle K, et al. Effects of glucagon-like peptide 1 on counter regulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic,stepped hypoglycemic clamp experiments in healthy volunteers [J]. J Clin Endocrinol Metab, 2002, 87 ( 6 ) : 1239-1246.
  • 2Xu L, Man CD,Charbonnel B, et al. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach [ J ]. Diabetes Obes Metab,2008 ,10(12) : 1212-1220.
  • 3Del Prato S, Marchetti P. Bete and alpha cell dysfunction in type 2 diabetes[J]. Horm Metab Res, 2004, 36(11/12) : 775-781.
  • 4Mu J, Petrov A, Eiermann GJ, et al. Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes [J]. Eur J Pharmacol,2009,623 (1/3) : 148-154.
  • 5Hong ES, Khang AR, Yoon JW, et al. Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study [ J ]. Diabetes Obes Metab, 2012,14 ( 9 ) : 795-802.
  • 6Toft-Nielsen MB, Damhoh MB, Madsbad S, et al. Determinants of the impaired secretion of glucagon-like peptidel in type 2 diabetic patients [ J ]. J Clin Endocrinol Metab, 2001, 86(8) : 3717-3723.
  • 7Nauck MA. Unraveling the science of incretin biology [ J ]. Am J Med,2009,122(6 Suppl) : S3-S10.
  • 8兰志新.沙格列汀治疗糖尿病的疗效观察[J].实用心脑肺血管病杂志,2012,18(7):107-108.
  • 9方丽娟,刘乃丰.沙格列汀联合门冬胰岛素30注射液治疗老年2型糖尿病的临床研究[J].中国临床药理学与治疗学,2012,16(2):118-122.
  • 10黄世杰.西格列汀联合大剂量胰岛素治疗老年2型糖尿病患者的临床疗效观察[J].实用老年医学研究杂志,2013,34(5):75-77.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部